Close menu



Secukinumab-like - Labelled (Arg,Lys) 13C15N


Quantification of Secukinumab

Specific labelling

Arginine: 13C6,15N4>99%

Lysine: 13C6,15N2, >99%


Labelled Secukinumab-like is a recombinant, stable isotope labelled monoclonal IgG1-Kappa antibody containing proteotypic peptides derived from Secukinumab’s originator sequence. Labelled Secukinumab-like is designed for use as an internal standard for quantitative analysis of Secukinumab in plasma samples. Secukinumab targets IL-17A cytokine and is used to treat duveitis, rheumatoid arthritis, ankylosing spondylitis, and psoriasis.

This product is for research use only and is not intended for diagnostic or therapeutic use.